Physician
Chinese Hospital Association
Chinese Hospital Association was paid $5.79M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is 77067, Screening mammography, bilateral, including computer-aided detection — 8.6% of everything it billed.
33Billing provider infoCHINESE HOSPITAL ASSOCIATION
SAN FRANCISCO, CA 94133
SAN FRANCISCO, CA 94133
33aNPI1992898837assigned 10/02/2006
33bProvider typeInterventional Cardiology Physician
28Total paid$5.79M
24GClaims266,832
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Interventional Cardiology Physician providers in California
Rank by total paid#3 of 125
Median peer was paid$32K
This provider vs. median181×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,779 | $129K | |
| 2019 | 27,720 | $211K | |
| 2020 | 36,330 | $664K | |
| 2021 | 55,166 | $1.15M | |
| 2022 | 45,577 | $749K | |
| 2023 | 46,655 | $1.80M | |
| 2024incomplete | 32,605 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8.6% | 4,099 | 4,039 | $497K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.9% | 1,454 | 1,394 | $344K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.6% | 942 | 919 | $264K |
| 80061 | Lipid panel | 4.5% | 18,461 | 18,199 | $262K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4.3% | 2,940 | 2,854 | $248K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.2% | 9,158 | 9,058 | $243K |
| 80053 | Comprehensive metabolic panel | 4.2% | 23,141 | 22,158 | $243K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.0% | 4,462 | 4,113 | $231K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.9% | 1,103 | 998 | $226K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 16,301 | 16,099 | $181K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.9% | 1,943 | 1,876 | $165K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 8,290 | 8,193 | $143K |
172 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 19,081 | $135K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 1,227 | $121K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 417 | $116K |
| 77080 | 1.9% | 1,506 | $112K | |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 2,971 | $108K |
| 87517 | 1.7% | 1,750 | $96K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 865 | $95K |
| 0064A | 1.2% | 1,798 | $71K | |
| 82274 | 1.1% | 3,882 | $65K | |
| 86480 | 1.1% | 937 | $62K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 3,557 | $61K |
| 80050 | General health panel | 1.0% | 607 | $59K |
| 71250 | <1% | 429 | $58K | |
| 0012A | <1% | 1,448 | $58K | |
| 0011A | <1% | 1,483 | $57K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 10,690 | $55K |
| 84153 | <1% | 2,608 | $54K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,417 | $54K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 289 | $49K |
| 86706 | <1% | 3,344 | $47K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 7,181 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 362 | $44K |
| 82043 | <1% | 7,139 | $43K | |
| 87340 | <1% | 3,231 | $43K | |
| 84439 | <1% | 4,050 | $41K | |
| 82105 | <1% | 1,637 | $40K | |
| 0450 | Emergency room services | <1% | 1,967 | $36K |
| 82570 | <1% | 7,099 | $35K | |
| 86803 | <1% | 1,929 | $33K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 205 | $30K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 362 | $29K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 206 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 516 | $26K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 493 | $26K |
| 83880 | <1% | 781 | $26K | |
| 86704 | <1% | 1,602 | $25K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 837 | $24K |
| 76770 | <1% | 239 | $23K | |
| 73562 | <1% | 769 | $20K | |
| 82607 | <1% | 1,462 | $19K | |
| 84466 | <1% | 1,278 | $17K | |
| 86708 | <1% | 1,055 | $17K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 152 | $17K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 62 | $16K |
| 81001 | <1% | 4,757 | $16K | |
| 0710 | <1% | 942 | $15K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 203 | $15K |
| 82728 | <1% | 1,050 | $15K | |
| 0250 | <1% | 3,488 | $14K | |
| 85027 | <1% | 1,633 | $14K | |
| 76536 | <1% | 172 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 310 | $13K |
| 83970 | <1% | 366 | $13K | |
| 0134A | <1% | 373 | $13K | |
| 84550 | <1% | 2,653 | $12K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,045 | $12K |
| 82746 | <1% | 898 | $11K | |
| 81003 | <1% | 4,410 | $11K | |
| 99152 | <1% | 224 | $11K | |
| 72114 | <1% | 99 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 551 | $11K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 67 | $10K |
| 84484 | <1% | 1,686 | $10K | |
| 84480 | <1% | 612 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 233 | $10K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 27 | $9K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | <1% | 352 | $9K |
| 83540 | <1% | 1,291 | $9K | |
| 72110 | <1% | 163 | $9K | |
| 83013 | <1% | 137 | $8K | |
| 0270 | <1% | 993 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,002 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 152 | $8K |
| 83690 | <1% | 1,640 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,805 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,032 | $7K |
| 76641 | <1% | 87 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 94 | $6K |
| 0072A | <1% | 147 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,972 | $6K |
| 72050 | <1% | 66 | $6K | |
| 0071A | <1% | 141 | $6K | |
| 72100 | <1% | 121 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 92 | $5K |
| 85610 | <1% | 1,474 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 683 | $5K |
| 83735 | <1% | 663 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 391 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,436 | $4K |
| 0031A | <1% | 122 | $4K | |
| 83090 | <1% | 183 | $4K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 778 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 57 | $4K |
| 82270 | <1% | 831 | $4K | |
| 73030 | <1% | 114 | $3K | |
| 0124A | <1% | 104 | $3K | |
| 72141 | <1% | 14 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 278 | $3K |
| 86765 | <1% | 146 | $3K | |
| 93225 | <1% | 12 | $2K | |
| 83921 | <1% | 110 | $2K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 1,342 | $2K |
| 87350 | <1% | 166 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 614 | $2K |
| 86735 | <1% | 131 | $2K | |
| 84100 | <1% | 293 | $2K | |
| 72070 | <1% | 67 | $2K | |
| 72170 | <1% | 51 | $2K | |
| 90656 | <1% | 20 | $2K | |
| 96367 | <1% | 105 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 791 | $2K |
| 85651 | <1% | 483 | $2K | |
| 86707 | <1% | 150 | $1K | |
| 0154A | <1% | 36 | $1K | |
| 86140 | <1% | 235 | $1K | |
| 73630 | <1% | 25 | $1K | |
| 86762 | <1% | 72 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 614 | $1K |
| 86038 | <1% | 82 | $1K | |
| 86787 | <1% | 73 | $1K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 67 | $999.72 |
| 96415 | <1% | 53 | $928.33 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 28 | $899.68 |
| V2632 | Posterior chamber intraocular lens | <1% | 88 | $840.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 51 | $755.75 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 29 | $548.40 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34 | $546.04 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 92 | $512.83 |
| 84156 | <1% | 99 | $511.39 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 63 | $507.32 |
| 0272 | <1% | 1,603 | $487.08 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 499 | $459.64 |
| 73130 | <1% | 12 | $457.50 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 162 | $456.93 |
| A4217 | Sterile water/saline, 500 ml | <1% | 80 | $450.20 |
| 83605 | <1% | 85 | $445.56 | |
| 74018 | <1% | 15 | $285.53 | |
| Z7502 | <1% | 69 | $213.13 | |
| 96127 | <1% | 12 | $207.84 | |
| 85730 | <1% | 42 | $197.87 | |
| 86430 | <1% | 26 | $191.43 | |
| 0258 | <1% | 1,313 | $181.07 | |
| 87184 | <1% | 27 | $177.61 | |
| 86592 | <1% | 28 | $144.13 | |
| 86431 | <1% | 12 | $90.49 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 138 | $89.50 |
| 99201 | <1% | 13 | $89.32 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 13 | $62.24 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 207 | $57.31 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $57.20 |
| 85041 | <1% | 26 | $9.23 | |
| 87400 | <1% | 19 | $8.11 | |
| J0897 | Injection, denosumab, 1 mg | <1% | 19 | $4.96 |
| 91306 | 0% | 12 | $0.00 | |
| 0250R | 0% | 981 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 17 | $0.00 |
| 0370 | 0% | 327 | $0.00 | |
| 0305 | 0% | 42 | $0.00 | |
| 0301 | 0% | 42 | $0.00 | |
| 0306 | 0% | 12 | $0.00 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 42 | $0.00 |
| 93016 | 0% | 13 | $0.00 | |
| 93018 | 0% | 13 | $0.00 | |
| 0258R | 0% | 385 | $0.00 | |
| 0272R | 0% | 395 | $0.00 | |
| 0710R | 0% | 140 | $0.00 | |
| 0270R | 0% | 140 | $0.00 | |
| 0370R | 0% | 90 | $0.00 | |
| 91313 | 0% | 12 | $0.00 | |
| 0300 | 0% | 42 | $0.00 | |
| 0120 | 0% | 28 | $0.00 | |
| 72131 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTAUFFER, JUDITH (MANAGER, PATIENT FINANCIAL SERVICES)